Neoadjuvant chemotherapy response in breast cancer patients with germline BRCA pathogenic variants

被引：0
|
作者：
Mimata, A. [1 ]
Takahashi, Y. [1 ]
Mamori, T. [1 ]
Nakamoto, S. [1 ]
Tsukioki, T. [1 ]
Iwatani, Y. [1 ]
Tanioka, M. [1 ]
Iwatani, T. [1 ]
Shien, T. [1 ]
机构：
[1] Okayama Univ, Okayama, Japan
来源：
BREAST | 2025年 / 80卷
关键词：
D O I：
10.1016/j.breast.2025.104073
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P232
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline BRCA Pathogenic Variant
    Litton, Jennifer K.
    Scoggins, Marion E.
    Hess, Kenneth R.
    Adrada, Beatriz E.
    Murthy, Rashmi K.
    Damodaran, Senthil
    DeSnyder, Sarah M.
    Brewster, Abenaa M.
    Barcenas, Carlos H.
    Valero, Vicente
    Whitman, Gary J.
    Schwartz-Gomez, Jill
    Mittendorf, Elizabeth A.
    Thompson, Alastair M.
    Helgason, Thorunn
    Ibrahim, Nuhad
    Piwnica-Worms, Helen
    Moulder, Stacy L.
    Arun, Banu K.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [2] BRCA pathogenic variants in luminal B breast cancer: A game changer for pathologic complete response in neoadjuvant chemotherapy?
    Di Leone, A.
    Castagnetta, V.
    Di Guglielmo, E.
    Accetta, C.
    Carnassale, B.
    D'Archi, S.
    De Lauretis, F.
    Franco, A.
    Gagliardi, F.
    Magno, S.
    Moschella, F.
    Natale, M.
    Sanchez, A. M.
    Scardina, L.
    Silenzi, M.
    Masetti, R.
    Franceschini, G.
    BREAST, 2025, 80
  • [3] Potential candidates for adjuvant olaparib treatment in operable breast cancer patients with germline BRCA1/2 pathogenic variants after neoadjuvant chemotherapy
    Liu, Huimin
    Kou, Furong
    Hu, Li
    Sun, Jie
    Zhang, Juan
    Xu, Ye
    Yao, Lu
    Xie, Yuntao
    BREAST CANCER RESEARCH AND TREATMENT, 2025, : 705 - 715
  • [4] The impact of germline BRCA pathogenic variants in locally advanced, triple negative breast cancer treated with platinum-based neoadjuvant chemotherapy
    Raz Mutai
    Iryna Kuchuk
    Alexandra Goldshtein
    Rinat Yerushalmi
    Ofer Rotem
    Adi Maisel Lotan
    Tali Bdolah-Abram
    Alberto Gabizon
    Hadar Goldvaser
    Breast Cancer Research and Treatment, 2024, 205 : 241 - 248
  • [5] The impact of germline BRCA pathogenic variants in locally advanced, triple negative breast cancer treated with platinum-based neoadjuvant chemotherapy
    Mutai, Raz
    Kuchuk, Iryna
    Goldshtein, Alexandra
    Yerushalmi, Rinat
    Rotem, Ofer
    Lotan, Adi Maisel
    Bdolah-Abram, Tali
    Gabizon, Alberto
    Goldvaser, Hadar
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 205 (02) : 241 - 248
  • [6] Postpartum Breast Cancer and Survival in Women With Germline BRCA Pathogenic Variants
    Zhang, Zhenzhen
    Ye, Shangyuan
    Bernhardt, Sarah M.
    Nelson, Heidi D.
    Velie, Ellen M.
    Borges, Virginia F.
    Woodward, Emma R.
    Evans, D. Gareth R.
    Schedin, Pepper J.
    JAMA NETWORK OPEN, 2024, 7 (04) : E247421
  • [7] Management Strategies of Breast Cancer Patients with BRCA1 and BRCA2 Pathogenic Germline Variants
    Edaily, Sarah
    Abdel-Razeq, Hikmat
    ONCOTARGETS AND THERAPY, 2022, 15 : 815 - 826
  • [8] Prevalence of germline BRCA pathogenic variants in a monoinstitutional cohort of patients with triple negative breast cancer
    De Matteis, E.
    Ciccarese, M.
    Ronzino, G.
    Forcignano, R.
    Chiuri, V. E.
    Cairo, G.
    Bovenga, I.
    Spro, E.
    De Giorgio, M. R.
    Tarantino, P.
    Palma, L.
    Mauro, S.
    Leo, S.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S79 - S79
  • [9] Pathogenic Germline Variants in Patients With Metastatic Breast Cancer
    Stuttgen, Kelsey
    Croessmann, Sarah
    Fetting, John
    Stearns, Vered
    Nunes, Raquel
    Connolly, Roisin M.
    Park, Ben Ho
    JAMA ONCOLOGY, 2019, 5 (10) : 1506 - 1508
  • [10] Pathogenic Germline Variants in Patients With Metaplastic Breast Cancer
    Demarest, Kaitlin
    Anantharajah, Arravinth
    Maxwell, Kara N.
    Rohanizadegan, Mersedeh
    Bradbury, Angela
    Nathanson, Katherine L.
    Mccarthy, Anne Marie
    Domchek, Susan M.
    Nayak, Anupma
    Shah, Payal D.
    JAMA NETWORK OPEN, 2025, 8 (02)
12345